These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22580285)

  • 1. Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aβ oligomers.
    Kasai T; Tokuda T; Taylor M; Nakagawa M; Allsop D
    Biochem Biophys Res Commun; 2012 Jun; 422(3):375-80. PubMed ID: 22580285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples.
    Kasai T; Tokuda T; Taylor M; Kondo M; Mann DM; Foulds PG; Nakagawa M; Allsop D
    Neurosci Lett; 2013 Sep; 551():17-22. PubMed ID: 23811027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
    Fukumoto H; Tokuda T; Kasai T; Ishigami N; Hidaka H; Kondo M; Allsop D; Nakagawa M
    FASEB J; 2010 Aug; 24(8):2716-26. PubMed ID: 20339023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ measurement by enzyme-linked immunosorbent assay.
    Schmidt SD; Mazzella MJ; Nixon RA; Mathews PM
    Methods Mol Biol; 2012; 849():507-27. PubMed ID: 22528112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology.
    Szekeres PG; Leong K; Day TA; Kingston AE; Karran EH
    J Biomol Screen; 2008 Feb; 13(2):101-11. PubMed ID: 18216395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and sensitivity of the Abeta oligomer ELISA.
    Klaver AC; Patrias LM; Finke JM; Loeffler DA
    J Neurosci Methods; 2011 Feb; 195(2):249-54. PubMed ID: 21163305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems.
    Jensen M; Hartmann T; Engvall B; Wang R; Uljon SN; Sennvik K; Näslund J; Muehlhauser F; Nordstedt C; Beyreuther K; Lannfelt L
    Mol Med; 2000 Apr; 6(4):291-302. PubMed ID: 10949910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates.
    van Helmond Z; Heesom K; Love S
    J Neurosci Methods; 2009 Jan; 176(2):206-12. PubMed ID: 18824027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I32E and V36K double mutation in beta2-sheet abrogates amyloid beta peptide toxicity.
    Subramanian S; Mishra PK; Bandopadhyay D
    Indian J Exp Biol; 2010 Nov; 48(11):1098-102. PubMed ID: 21117449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput monitoring of amyloid-β(42) assembly into soluble oligomers achieved by sensitive conformation state-dependent immunoassays.
    Zhao WQ; Toolan D; Hepler RW; Wolfe AL; Yu Y; Price E; Uebele VN; Schachter JB; Reynolds IJ; Renger JJ; McCampbell A; Ray WJ
    J Alzheimers Dis; 2011; 25(4):655-69. PubMed ID: 21483096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a monoclonal antibody with high affinity for soluble Abeta oligomers.
    Ying Z; Xin W; Jin-Sheng H; Fu-Xiang B; Wei-Min S; Xin-Xian D; Xiao-Bo W; Yi-Qin L; Xian-Xian Z; Hong-Gang H; Xiang-Lei P; Yan-Peng Z; Ling-Ling H; Tao H
    Hybridoma (Larchmt); 2009 Oct; 28(5):349-54. PubMed ID: 19857116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of amyloid-β42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice.
    Zhang Y; He JS; Wang X; Wang J; Bao FX; Pang SY; Yin F; Hu HG; Peng XL; Sun WM; Zheng YP; Hou LL; Hong T
    J Alzheimers Dis; 2011; 23(3):551-61. PubMed ID: 21297277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.
    Klyubin I; Walsh DM; Lemere CA; Cullen WK; Shankar GM; Betts V; Spooner ET; Jiang L; Anwyl R; Selkoe DJ; Rowan MJ
    Nat Med; 2005 May; 11(5):556-61. PubMed ID: 15834427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and mapping of linear antigenic determinants of human amyloid ß(1-42) peptide.
    Subramanian S; D'Souza R; Divya Shree AN
    J Immunoassay Immunochem; 2012 Jan; 33(1):26-34. PubMed ID: 22181818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.
    Yang T; Hong S; O'Malley T; Sperling RA; Walsh DM; Selkoe DJ
    Alzheimers Dement; 2013 Mar; 9(2):99-112. PubMed ID: 23375565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
    Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
    Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.